GLP-1 Drugs Like Ozempic Face a New Test: Multiple Sclerosis
A new narrative review finds that GLP-1 receptor agonists like semaglutide and tirzepatide are safe and effective for weight loss ...
A new narrative review finds that GLP-1 receptor agonists like semaglutide and tirzepatide are safe and effective for weight loss ...
A decade-long Henry Ford Health study found that 72 percent of emergency department visits for hidradenitis suppurativa led to hospital ...
The clinical scenario described in this case highlights a therapeutic dilemma that nephrologists and rheumatologists face with increasing frequency as ...
A comprehensive review details how three FDA-approved therapies have dramatically improved spinal muscular atrophy outcomes while highlighting persistent comorbidities and ...
A first-of-its-kind Portuguese study of 234 adults with intellectual disabilities aged 45 and older finds that nearly half are frail, ...
A large NIH All of Us analysis found that men with prurigo nodularis had significantly higher odds of erectile dysfunction, ...
A cross-sectional study of 626 surgical head and neck cancer patients in China finds that higher nutritional knowledge and practice ...
A new retrospective cohort study examines the risk of new-onset metabolic comorbidities in Hispanic and Latino patients with psoriasis vulgaris, ...
A new systematic review and meta-analysis from Stony Brook researchers examines whether children with atopic dermatitis face an elevated risk ...
A new retrospective cohort study from Henry Ford Health examines whether women with hidradenitis suppurativa adhere to breast cancer screening ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine